Collegium Pharmaceutical Inc (COLL)
Collegium Pharmaceutical stock today
Collegium Pharmaceutical closed at $23.80 on October 30, 2026, down 0.96% on the day. Over the past year it returned -33.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $772 million.
| Period | COLL | S&P 500 (SPY) |
|---|---|---|
| 1 month | +9.1% | -0.9% |
| 3 months | -33.9% | +2.1% |
| Year to date | -48.6% | +11.7% |
| 1 year | -33.2% | +12.4% |
| 3 years | +9.6% | +88.5% |
| 5 years | +21.2% | +76.0% |
Key statistics
- Market value
- $772M
- P/E (trailing)
- 19.2
- Forward P/E
- 3.2
- Price / sales
- 1.0
- 52-week range
- $21.53 to $49.84
- Next report
- Nov 5, 2026
About Collegium Pharmaceutical
Develops and markets pharmaceutical products, primarily pain management medications.
Sector: Health Care
More on Collegium Pharmaceutical
- Financials: revenue, earnings and segmentsRevenue +24% in the year to Dec 2025
- Valuation: P/E history and peersP/E 19.2, median 26.1 at its last 5 year ends
- Returns: what $1,000 became$1,000 ten years ago is $1,563 today
No forecast, no recommendation. This page describes Collegium Pharmaceutical Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.